The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-cyanophenyl 4-cyclopropylpiperazine-1-carboxylate ID: ALA4557262
PubChem CID: 155554535
Max Phase: Preclinical
Molecular Formula: C15H17N3O2
Molecular Weight: 271.32
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1cccc(OC(=O)N2CCN(C3CC3)CC2)c1
Standard InChI: InChI=1S/C15H17N3O2/c16-11-12-2-1-3-14(10-12)20-15(19)18-8-6-17(7-9-18)13-4-5-13/h1-3,10,13H,4-9H2
Standard InChI Key: ZORJTHKAWROIGI-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
37.3548 -16.3971 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.0617 -16.8079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7708 -16.4017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7738 -15.5800 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.0614 -15.1663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3462 -15.5783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4865 -15.1689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1933 -15.5832 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.4883 -14.3476 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.9060 -15.1720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6157 -15.5900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3279 -15.1795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3302 -14.3573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6143 -13.9473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9049 -14.3560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.0356 -15.5905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.7464 -16.0010 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.6441 -16.8075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8255 -16.8112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2401 -17.5220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
4 7 1 0
7 8 1 0
7 9 2 0
8 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
16 17 3 0
12 16 1 0
1 18 1 0
19 18 1 0
20 19 1 0
18 20 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 271.32Molecular Weight (Monoisotopic): 271.1321AlogP: 1.84#Rotatable Bonds: 2Polar Surface Area: 56.57Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.89CX LogP: 1.86CX LogD: 1.75Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.82Np Likeness Score: -1.68
References 1. Alapafuja SO, Malamas MS, Shukla V, Zvonok A, Miller S, Daily L, Rajarshi G, Miyabe CY, Chandrashekhar H, Wood J, Tyukhtenko S, Straiker A, Makriyannis A.. (2019) Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment., 27 (1): [PMID:30446439 ] [10.1016/j.bmc.2018.11.003 ]